Pancreatoduodenectomy for Distal Cholangiocarcinoma: Prognostic Impact of Lymph Node Metastasis
-
- Yoshiaki Murakami
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
-
- Kenichiro Uemura
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
-
- Yasuo Hayashidani
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
-
- Takeshi Sudo
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
-
- Hiroki Ohge
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
-
- Taijiro Sueda
- Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences Hiroshima University 1‐2‐3 Kasumi 734‐8551 Minami‐ku Hiroshima Japan
書誌事項
- 公開日
- 2006-09-07
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1007/s00268-006-0224-0
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The aim of this study was to identify useful prognostic factors in patients undergoing pancreatoduodenectomy for distal cholangiocarcinoma.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The records of 36 patients with distal cholangiocarcinoma undergoing pancreatoduodenectomy were retrospectively reviewed. Potential clinicopathological prognostic factors that may affect survival were examined by univariate and multivariate analysis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There was no mortality. Overall survival rates were 75%, 54%, and 50% for 1, 3 and 5 years, respectively (median survival time, 26 months). Univariate analysis found that age (≧ 65 years), pancreatic invasion, duodenal invasion, lymph node metastasis, perineural invasion and a positive surgical margin were significant predictors of poor prognosis (<jats:italic>P</jats:italic> < 0.05). Furthermore, lymph node metastasis was found to be a significant independent predictor of poor prognosis by multivariate analysis (<jats:italic>P</jats:italic> = 0.043). Moreover, there were significant differences in the 5‐year survival between patients with 2 or less involved lymph nodes and those with 3 or more positive nodes (<jats:italic>P</jats:italic> < 0.001). There were no 2‐year survivors of the group of patients with 3 or more positive nodes.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>These results suggest that the presence and number of lymph nodes exhibiting metastatic disease might be useful in predicting the postsurgical outcome in patients undergoing pancreatoduodenectomy for distal cholangiocarcinoma.</jats:p></jats:sec>
収録刊行物
-
- World Journal of Surgery
-
World Journal of Surgery 31 (2), 337-342, 2006-09-07
Wiley